Table 3 Diagnostic performance of clinical outcome assessment after percutaneous transluminal angioplasty
Modality | Reviewer | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | Accuracy (95% CI) |
|---|---|---|---|---|---|---|
DSA | A | 41.7(22.1, 63.4) | 82.7(69.7, 91.8) | 52.6(28.9, 75.6) | 75.4(62.2, 85.9) | 69.7(58.1, 79.8) |
B | 47.4(24.4, 71.1) | 82.5(70.1, 91.3) | 47.4(24.4, 71.1) | 82.5(70.1, 90.0) | 73.7(62.3, 83.1) | |
iFlow | A | 50.0(29.1, 70.9) | 86.5(74.2, 94.4) | 63.2(38.4, 83.7) | 78.9(66.1, 88.6) | 75.0(63.7, 84.2) |
B | 61.1(35.7, 82.7) | 86.2(74.6, 93.9) | 57.9(33.5, 79.7) | 87.7(76.3, 94.9) | 80.3(69.5, 88.5) |